应用「Vent技术」腔内治疗近肾腹主动脉瘤
本文报告5例近肾腹主动脉瘤患者采用裸金属支架联合超低剖面Ovation内移植物行腔内治疗的经验。术中无并发症及IA型内漏,1个月原发临床成功率100%;平均随访12.1±3.6个月(范围9-15个月)无动脉瘤相关并发症。该技术为开放手术高危患者提供有效腔内选择,较传统烟囱技术降低IA型内漏风险。
要点
- 裸金属支架联合Ovation内移植物可用于近肾腹主动脉瘤腔内治疗
- 5例患者术中无并发症及IA型内漏,1个月原发临床成功率100%
- 较传统烟囱技术降低IA型内漏风险及随访再干预率
核心结论
- 该技术为开放手术高危的近肾腹主动脉瘤患者提供有效腔内治疗选择。
- 较FEVAR可治疗急诊患者,较传统烟囱技术降低IA型内漏风险及随访再干预率。
- 初步临床结果令人鼓舞。
研究设计与样本
- 单中心经验报告,纳入5例近肾腹主动脉瘤患者。
- 采用裸金属支架联合超低剖面Ovation内移植物行腔内治疗。
- 平均随访12.1±3.6个月(范围9-15个月)。
主要发现
- 术中无并发症,无IA型内漏记录。
- 1个月原发临床成功率为100%。
- 随访期间无动脉瘤相关并发症记录。
关键数值与推荐
- 近肾腹主动脉瘤占全部腹主动脉瘤的15-20%。
- FEVAR需3-4周定制内移植物,近端瘤颈最短需4 mm,需较大入路血管直径且费用高。
- 传统烟囱技术因内脏动脉覆膜支架与内移植物间空隙存在IA型内漏风险。
临床怎么用
- 对开放手术高危的近肾腹主动脉瘤患者可考虑该腔内技术。
- 急诊患者可考虑该技术,无需等待FEVAR定制内移植物。
- 该技术较传统烟囱技术可能降低IA型内漏及再干预风险。
局限性
- 样本量仅5例,随访时间平均12.1±3.6个月,为初步经验。
- 原文未报告对照设计及长期随访结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Juxtarenal abdominal aortic aneurysms represent 15-20% of all abdominal aortic aneurysms (AAAs). The gold standard of treatment is represented by open surgical repair (OSR). Patients judged unfit for OSR could be submitted to fenestrated endovascular aortic repair (FEVAR) or the chimney technique. FEVAR requires 3-4 weeks for endograft production, a minimal length of 4 mm for proximal aortic neck and a large access vessels diameter, with high costs. The traditional chimney technique, feasible also in urgent cases, has a risk of type IA endoleak due to the space created between covered stents introduced into visceral arteries and the endograft. METHODS: In the present article, we report our experience about juxtarenal AAA (jAAA) treatment in 5 patients, recurring to uncovered bare metal stents associated with the ultralow profile Ovation endograft. RESULTS: No intraoperative complications or type IA endoleaks were recorded. Primary clinical success at 1 month was also 100%. During a mean follow-up period of 12.1 ± 3.6 months (range, 9-15 months), no complications related to aneurysm were recorded. CONCLUSIONS: The technique reported represents a valid endovascular option for jAAA treatment in patients at high risk for OSR. With respect to FEVAR, urgent patients should also be treated. With respect to traditional Ch-EVAR, the risk of type IA endoleak is reduced, with a lower rate of reoperation during follow-up. Preliminary clinical results are promising.
引用
- Volpe P, Alberti A, Massara M, et al. Endovascular Treatment of Juxtarenal Abdominal Aortic Aneurysms Recurring to the "Vent Technique". Ann Vasc Surg. 2020. PMID: 32283300. doi:10.1016/j.avsg.2020.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。